 Thomas Jansson
Concepts (452)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Placenta | 90 | 2025 | 719 | 18.660 |
Why?
| | Trophoblasts | 42 | 2025 | 190 | 10.070 |
Why?
| | Fetal Growth Retardation | 40 | 2025 | 547 | 9.360 |
Why?
| | TOR Serine-Threonine Kinases | 45 | 2025 | 396 | 8.080 |
Why?
| | Fetal Development | 30 | 2025 | 286 | 6.780 |
Why?
| | Maternal-Fetal Exchange | 24 | 2021 | 161 | 5.650 |
Why?
| | Pregnancy | 130 | 2025 | 6390 | 5.470 |
Why?
| | Amino Acids | 23 | 2024 | 483 | 4.900 |
Why?
| | Amino Acid Transport System A | 13 | 2025 | 37 | 4.810 |
Why?
| | Amino Acid Transport Systems | 16 | 2024 | 42 | 4.680 |
Why?
| | Diabetes, Gestational | 17 | 2023 | 308 | 4.430 |
Why?
| | Adiponectin | 14 | 2024 | 235 | 4.050 |
Why?
| | Insulin-Like Growth Factor Binding Protein 1 | 16 | 2023 | 26 | 3.590 |
Why?
| | Pregnancy Complications | 15 | 2024 | 492 | 3.560 |
Why?
| | Insulin | 30 | 2023 | 2325 | 3.120 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 15 | 2024 | 119 | 3.080 |
Why?
| | Obesity | 24 | 2025 | 2880 | 2.990 |
Why?
| | Insulin-Like Growth Factor I | 16 | 2023 | 307 | 2.860 |
Why?
| | Signal Transduction | 44 | 2025 | 4924 | 2.780 |
Why?
| | Glucose Intolerance | 5 | 2022 | 142 | 2.770 |
Why?
| | Maternal Nutritional Physiological Phenomena | 12 | 2024 | 169 | 2.710 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 9 | 2023 | 62 | 2.470 |
Why?
| | Fetal Macrosomia | 11 | 2023 | 62 | 2.350 |
Why?
| | Amino Acid Transport System L | 7 | 2025 | 19 | 2.310 |
Why?
| | Folic Acid | 7 | 2021 | 184 | 2.250 |
Why?
| | Birth Weight | 14 | 2021 | 504 | 2.140 |
Why?
| | Papio | 14 | 2021 | 91 | 2.030 |
Why?
| | Pregnancy Proteins | 6 | 2022 | 37 | 1.940 |
Why?
| | Prenatal Exposure Delayed Effects | 9 | 2024 | 573 | 1.920 |
Why?
| | Female | 135 | 2025 | 68686 | 1.910 |
Why?
| | Fetus | 16 | 2024 | 772 | 1.830 |
Why?
| | Biological Transport | 18 | 2024 | 401 | 1.810 |
Why?
| | Placental Insufficiency | 5 | 2019 | 111 | 1.800 |
Why?
| | Folate Receptor 1 | 4 | 2019 | 15 | 1.640 |
Why?
| | Decidua | 7 | 2022 | 23 | 1.620 |
Why?
| | Cell Membrane | 11 | 2020 | 732 | 1.560 |
Why?
| | Fetal Weight | 7 | 2021 | 56 | 1.560 |
Why?
| | Placentation | 6 | 2021 | 44 | 1.510 |
Why?
| | Insulin Resistance | 10 | 2024 | 1165 | 1.490 |
Why?
| | Multiprotein Complexes | 6 | 2015 | 154 | 1.460 |
Why?
| | Animals | 63 | 2025 | 35346 | 1.380 |
Why?
| | Glucose Transporter Type 1 | 5 | 2020 | 49 | 1.350 |
Why?
| | Down-Regulation | 8 | 2020 | 636 | 1.270 |
Why?
| | Extracellular Vesicles | 2 | 2022 | 130 | 1.270 |
Why?
| | Folic Acid Deficiency | 3 | 2021 | 48 | 1.270 |
Why?
| | Receptors, Adiponectin | 4 | 2024 | 19 | 1.230 |
Why?
| | Fetal Nutrition Disorders | 3 | 2015 | 7 | 1.210 |
Why?
| | Phosphorylation | 23 | 2023 | 1713 | 1.160 |
Why?
| | Pregnancy Trimester, First | 7 | 2021 | 138 | 1.130 |
Why?
| | Blood Glucose | 7 | 2023 | 2096 | 1.110 |
Why?
| | Heart Diseases | 2 | 2022 | 350 | 1.100 |
Why?
| | Fatty Liver | 2 | 2022 | 231 | 1.080 |
Why?
| | Humans | 108 | 2025 | 129378 | 1.040 |
Why?
| | Diet, Protein-Restricted | 2 | 2021 | 11 | 1.020 |
Why?
| | Leucine | 7 | 2021 | 108 | 0.980 |
Why?
| | Intracellular Signaling Peptides and Proteins | 6 | 2025 | 442 | 0.980 |
Why?
| | Cells, Cultured | 22 | 2021 | 4082 | 0.980 |
Why?
| | Gene Expression Regulation, Developmental | 4 | 2021 | 821 | 0.960 |
Why?
| | Gestational Age | 14 | 2021 | 873 | 0.940 |
Why?
| | Docosahexaenoic Acids | 6 | 2024 | 83 | 0.910 |
Why?
| | Transcriptome | 4 | 2022 | 887 | 0.880 |
Why?
| | Body Mass Index | 13 | 2024 | 2270 | 0.880 |
Why?
| | Adiposity | 4 | 2023 | 504 | 0.870 |
Why?
| | Lipid Metabolism | 7 | 2024 | 497 | 0.870 |
Why?
| | Reduced Folate Carrier Protein | 3 | 2019 | 10 | 0.860 |
Why?
| | Symporters | 1 | 2023 | 56 | 0.860 |
Why?
| | Infant, Newborn | 21 | 2023 | 5760 | 0.840 |
Why?
| | Pregnancy, Animal | 3 | 2014 | 53 | 0.840 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 2 | 2021 | 9 | 0.830 |
Why?
| | Caloric Restriction | 2 | 2015 | 110 | 0.810 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2023 | 138 | 0.790 |
Why?
| | Mice | 20 | 2025 | 16935 | 0.780 |
Why?
| | Overnutrition | 1 | 2022 | 30 | 0.760 |
Why?
| | Glucose Transport Proteins, Facilitative | 2 | 2014 | 12 | 0.740 |
Why?
| | Adult | 43 | 2025 | 35512 | 0.720 |
Why?
| | Glucose | 11 | 2022 | 1002 | 0.720 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2021 | 18 | 0.720 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2021 | 41 | 0.710 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 3 | 2021 | 274 | 0.710 |
Why?
| | Liver | 6 | 2023 | 1839 | 0.710 |
Why?
| | Pregnancy Trimester, Second | 2 | 2020 | 77 | 0.700 |
Why?
| | N-Acetylglucosaminyltransferases | 1 | 2020 | 22 | 0.700 |
Why?
| | Fatty Acid Transport Proteins | 4 | 2018 | 19 | 0.700 |
Why?
| | Membrane Transport Proteins | 3 | 2023 | 149 | 0.700 |
Why?
| | Overweight | 3 | 2017 | 530 | 0.680 |
Why?
| | Serotonin | 2 | 2020 | 321 | 0.680 |
Why?
| | Food Deprivation | 3 | 2020 | 21 | 0.680 |
Why?
| | Leptin | 4 | 2015 | 219 | 0.670 |
Why?
| | cdc42 GTP-Binding Protein | 1 | 2020 | 23 | 0.670 |
Why?
| | DNA Methylation | 3 | 2023 | 607 | 0.650 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2020 | 54 | 0.650 |
Why?
| | AMP-Activated Protein Kinases | 6 | 2022 | 189 | 0.640 |
Why?
| | Phospholipids | 4 | 2024 | 215 | 0.640 |
Why?
| | Apelin | 1 | 2019 | 9 | 0.630 |
Why?
| | Mice, Inbred C57BL | 11 | 2024 | 5438 | 0.630 |
Why?
| | Endosomal Sorting Complexes Required for Transport | 2 | 2015 | 35 | 0.620 |
Why?
| | Adaptor Proteins, Signal Transducing | 5 | 2015 | 399 | 0.590 |
Why?
| | Protein Kinases | 4 | 2019 | 318 | 0.590 |
Why?
| | PPAR gamma | 5 | 2022 | 183 | 0.590 |
Why?
| | Fatty Acid-Binding Proteins | 4 | 2018 | 69 | 0.590 |
Why?
| | Regulatory-Associated Protein of mTOR | 6 | 2019 | 18 | 0.580 |
Why?
| | Infant, Premature | 2 | 2022 | 540 | 0.580 |
Why?
| | Fusion Regulatory Protein 1, Light Chains | 2 | 2015 | 6 | 0.580 |
Why?
| | Endocrine Disruptors | 1 | 2018 | 40 | 0.570 |
Why?
| | Phthalic Acids | 1 | 2018 | 45 | 0.570 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 2015 | 153 | 0.560 |
Why?
| | Fatty Acids, Unsaturated | 4 | 2018 | 97 | 0.560 |
Why?
| | Mice, Obese | 4 | 2022 | 59 | 0.560 |
Why?
| | Metabolic Diseases | 1 | 2018 | 104 | 0.560 |
Why?
| | Proteome | 2 | 2019 | 443 | 0.560 |
Why?
| | Casein Kinase II | 7 | 2021 | 21 | 0.560 |
Why?
| | Specimen Handling | 1 | 2018 | 163 | 0.560 |
Why?
| | Glucocorticoids | 2 | 2019 | 574 | 0.550 |
Why?
| | Organ Size | 8 | 2021 | 447 | 0.550 |
Why?
| | Primary Cell Culture | 7 | 2019 | 160 | 0.550 |
Why?
| | RNA Interference | 5 | 2021 | 448 | 0.550 |
Why?
| | Maternal Exposure | 1 | 2018 | 177 | 0.520 |
Why?
| | Microvilli | 5 | 2019 | 79 | 0.510 |
Why?
| | Disease Models, Animal | 9 | 2022 | 4061 | 0.510 |
Why?
| | Homeostasis | 1 | 2020 | 611 | 0.510 |
Why?
| | Hormones | 2 | 2008 | 140 | 0.500 |
Why?
| | Chorionic Villi | 4 | 2019 | 22 | 0.500 |
Why?
| | Fetal Blood | 4 | 2024 | 316 | 0.490 |
Why?
| | Gene Expression Regulation | 6 | 2021 | 2548 | 0.480 |
Why?
| | Altitude | 1 | 2019 | 457 | 0.480 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 5 | 2015 | 59 | 0.480 |
Why?
| | RNA, Small Interfering | 6 | 2023 | 587 | 0.470 |
Why?
| | Diet, High-Fat | 5 | 2024 | 239 | 0.470 |
Why?
| | Rapamycin-Insensitive Companion of mTOR Protein | 5 | 2019 | 29 | 0.450 |
Why?
| | Case-Control Studies | 6 | 2021 | 3375 | 0.450 |
Why?
| | Weight Gain | 2 | 2015 | 510 | 0.440 |
Why?
| | Homocysteine | 2 | 2017 | 152 | 0.440 |
Why?
| | Male | 26 | 2025 | 63595 | 0.440 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2013 | 27 | 0.430 |
Why?
| | Ubiquitination | 3 | 2022 | 98 | 0.430 |
Why?
| | Vitamin D | 1 | 2016 | 383 | 0.420 |
Why?
| | Nutritional Status | 1 | 2015 | 328 | 0.410 |
Why?
| | Proton-Coupled Folate Transporter | 3 | 2019 | 10 | 0.400 |
Why?
| | Dietary Supplements | 4 | 2024 | 533 | 0.400 |
Why?
| | Placental Circulation | 6 | 2019 | 63 | 0.390 |
Why?
| | Fatty Acids | 5 | 2022 | 427 | 0.390 |
Why?
| | Nedd4 Ubiquitin Protein Ligases | 3 | 2016 | 15 | 0.380 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2022 | 431 | 0.380 |
Why?
| | Cardiovascular Diseases | 2 | 2022 | 2001 | 0.380 |
Why?
| | Pregnancy in Diabetics | 3 | 2021 | 118 | 0.380 |
Why?
| | PPAR alpha | 4 | 2015 | 58 | 0.350 |
Why?
| | Biological Availability | 2 | 2023 | 147 | 0.340 |
Why?
| | STAT3 Transcription Factor | 2 | 2014 | 195 | 0.340 |
Why?
| | Cohort Studies | 6 | 2023 | 5414 | 0.330 |
Why?
| | Oleic Acid | 3 | 2014 | 39 | 0.330 |
Why?
| | Dietary Fats | 2 | 2008 | 301 | 0.330 |
Why?
| | Dietary Proteins | 1 | 2011 | 128 | 0.330 |
Why?
| | Ion Transport | 1 | 2009 | 62 | 0.320 |
Why?
| | Carrier Proteins | 5 | 2021 | 743 | 0.320 |
Why?
| | Biomarkers | 6 | 2024 | 3972 | 0.320 |
Why?
| | Hypoxia | 3 | 2022 | 1081 | 0.310 |
Why?
| | Rats, Wistar | 8 | 2021 | 441 | 0.310 |
Why?
| | beta-Alanine | 2 | 2006 | 16 | 0.300 |
Why?
| | In Vitro Techniques | 5 | 2021 | 1083 | 0.300 |
Why?
| | RNA, Messenger | 6 | 2024 | 2707 | 0.300 |
Why?
| | Proteolysis | 2 | 2022 | 165 | 0.300 |
Why?
| | Rats | 10 | 2021 | 5497 | 0.300 |
Why?
| | Gene Knockdown Techniques | 4 | 2025 | 315 | 0.300 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 2 | 2023 | 15 | 0.290 |
Why?
| | Exosomes | 2 | 2019 | 96 | 0.290 |
Why?
| | Food | 1 | 2009 | 157 | 0.280 |
Why?
| | Amino Acid Transport Systems, Neutral | 1 | 2007 | 3 | 0.280 |
Why?
| | Endoplasmic Reticulum Stress | 2 | 2020 | 101 | 0.280 |
Why?
| | Malaria, Falciparum | 2 | 2017 | 26 | 0.280 |
Why?
| | Young Adult | 10 | 2024 | 12415 | 0.270 |
Why?
| | Choline | 2 | 2024 | 124 | 0.270 |
Why?
| | Hyperglycemia | 2 | 2007 | 328 | 0.260 |
Why?
| | Taurine | 1 | 2007 | 43 | 0.260 |
Why?
| | Protein Transport | 3 | 2021 | 428 | 0.260 |
Why?
| | Biological Transport, Active | 3 | 2015 | 78 | 0.260 |
Why?
| | Up-Regulation | 3 | 2015 | 839 | 0.260 |
Why?
| | Cesarean Section | 2 | 2022 | 182 | 0.250 |
Why?
| | CD36 Antigens | 2 | 2016 | 36 | 0.250 |
Why?
| | Adult Children | 2 | 2024 | 23 | 0.250 |
Why?
| | Hep G2 Cells | 7 | 2021 | 61 | 0.250 |
Why?
| | Hypoglycemic Agents | 3 | 2019 | 1219 | 0.240 |
Why?
| | Energy Intake | 1 | 2008 | 461 | 0.240 |
Why?
| | Chromatography, Liquid | 2 | 2023 | 423 | 0.230 |
Why?
| | Palmitic Acid | 2 | 2014 | 40 | 0.230 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2004 | 49 | 0.230 |
Why?
| | Cell Hypoxia | 3 | 2021 | 235 | 0.230 |
Why?
| | Protein Kinase C-alpha | 2 | 2021 | 37 | 0.230 |
Why?
| | Maternal Age | 3 | 2021 | 124 | 0.220 |
Why?
| | Gene Silencing | 4 | 2021 | 190 | 0.220 |
Why?
| | Amino Acids, Essential | 1 | 2023 | 13 | 0.220 |
Why?
| | Tandem Mass Spectrometry | 2 | 2023 | 524 | 0.220 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 2 | 2022 | 133 | 0.210 |
Why?
| | Term Birth | 2 | 2015 | 20 | 0.210 |
Why?
| | Embryonic Development | 2 | 2021 | 114 | 0.200 |
Why?
| | Umbilical Veins | 2 | 2014 | 61 | 0.200 |
Why?
| | Peroxisome Proliferator-Activated Receptors | 1 | 2022 | 15 | 0.200 |
Why?
| | Body Weight | 3 | 2012 | 940 | 0.190 |
Why?
| | 3T3-L1 Cells | 1 | 2022 | 34 | 0.190 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2023 | 112 | 0.190 |
Why?
| | Carnitine | 1 | 2022 | 76 | 0.190 |
Why?
| | Fetal Heart | 1 | 2022 | 55 | 0.190 |
Why?
| | Inflammation Mediators | 2 | 2015 | 505 | 0.190 |
Why?
| | Sirolimus | 5 | 2020 | 266 | 0.180 |
Why?
| | Animals, Newborn | 2 | 2018 | 835 | 0.180 |
Why?
| | Glucose Tolerance Test | 1 | 2022 | 356 | 0.180 |
Why?
| | MAP Kinase Signaling System | 3 | 2019 | 312 | 0.180 |
Why?
| | Intra-Abdominal Fat | 1 | 2022 | 88 | 0.180 |
Why?
| | Testosterone | 2 | 2016 | 371 | 0.180 |
Why?
| | Infant, Low Birth Weight | 2 | 2019 | 135 | 0.180 |
Why?
| | Cardiomegaly | 1 | 2022 | 172 | 0.180 |
Why?
| | Monoamine Oxidase | 1 | 2020 | 27 | 0.180 |
Why?
| | Vitrification | 1 | 2020 | 7 | 0.180 |
Why?
| | Triglycerides | 4 | 2023 | 527 | 0.170 |
Why?
| | Birth Rate | 1 | 2020 | 25 | 0.170 |
Why?
| | Infant | 4 | 2024 | 9023 | 0.170 |
Why?
| | Organogenesis | 1 | 2021 | 56 | 0.170 |
Why?
| | Blastocyst | 1 | 2020 | 47 | 0.170 |
Why?
| | Embryo Implantation | 1 | 2020 | 28 | 0.170 |
Why?
| | Embryo Transfer | 1 | 2020 | 33 | 0.170 |
Why?
| | Umbilical Cord | 1 | 2020 | 83 | 0.170 |
Why?
| | Cell Culture Techniques | 2 | 2021 | 345 | 0.170 |
Why?
| | Skinfold Thickness | 1 | 2020 | 46 | 0.170 |
Why?
| | Embryo, Mammalian | 1 | 2021 | 226 | 0.170 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2022 | 359 | 0.170 |
Why?
| | Adipocytes | 1 | 2022 | 205 | 0.170 |
Why?
| | Adipose Tissue | 2 | 2019 | 590 | 0.170 |
Why?
| | Child, Preschool | 4 | 2024 | 10516 | 0.160 |
Why?
| | Receptor, Insulin | 1 | 2019 | 99 | 0.160 |
Why?
| | Apelin Receptors | 1 | 2019 | 4 | 0.160 |
Why?
| | Myometrium | 1 | 2019 | 37 | 0.160 |
Why?
| | Pediatric Obesity | 2 | 2024 | 570 | 0.160 |
Why?
| | Organelle Biogenesis | 1 | 2019 | 15 | 0.160 |
Why?
| | Immunohistochemistry | 3 | 2018 | 1698 | 0.160 |
Why?
| | Enzyme Activation | 3 | 2015 | 811 | 0.160 |
Why?
| | Lysophosphatidylcholines | 1 | 2018 | 21 | 0.160 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2019 | 52 | 0.160 |
Why?
| | Protein Kinase C | 2 | 2021 | 259 | 0.150 |
Why?
| | Myoblasts, Skeletal | 1 | 2018 | 12 | 0.150 |
Why?
| | Metabolomics | 1 | 2024 | 652 | 0.150 |
Why?
| | Olive Oil | 1 | 2018 | 3 | 0.150 |
Why?
| | Electron Transport | 1 | 2019 | 112 | 0.150 |
Why?
| | Protein Interaction Maps | 1 | 2018 | 42 | 0.150 |
Why?
| | PPAR delta | 1 | 2018 | 5 | 0.150 |
Why?
| | Tetrahydrofolates | 1 | 2018 | 18 | 0.150 |
Why?
| | Models, Biological | 4 | 2021 | 1719 | 0.150 |
Why?
| | Lipids | 1 | 2022 | 625 | 0.150 |
Why?
| | Receptors, Glucocorticoid | 1 | 2019 | 147 | 0.150 |
Why?
| | Oxidative Phosphorylation | 1 | 2019 | 187 | 0.140 |
Why?
| | Child | 6 | 2024 | 20868 | 0.140 |
Why?
| | Piperidines | 1 | 2019 | 196 | 0.140 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2017 | 28 | 0.140 |
Why?
| | alpha-Linolenic Acid | 1 | 2017 | 8 | 0.140 |
Why?
| | Blood Platelets | 1 | 2020 | 380 | 0.140 |
Why?
| | Glyburide | 1 | 2017 | 35 | 0.140 |
Why?
| | Mice, Inbred ICR | 1 | 2017 | 110 | 0.140 |
Why?
| | Arachidonic Acid | 1 | 2017 | 115 | 0.140 |
Why?
| | Rats, Sprague-Dawley | 3 | 2007 | 2406 | 0.140 |
Why?
| | Pregnancy Complications, Parasitic | 1 | 2017 | 9 | 0.140 |
Why?
| | Protein Processing, Post-Translational | 3 | 2015 | 455 | 0.140 |
Why?
| | Phosphoproteins | 2 | 2011 | 332 | 0.130 |
Why?
| | Receptors, Calcitriol | 1 | 2016 | 54 | 0.130 |
Why?
| | Electroacupuncture | 1 | 2016 | 2 | 0.130 |
Why?
| | Muscle Contraction | 1 | 2019 | 422 | 0.130 |
Why?
| | Prenatal Diagnosis | 1 | 2018 | 190 | 0.130 |
Why?
| | Cholecalciferol | 1 | 2016 | 56 | 0.130 |
Why?
| | Resource Allocation | 1 | 2016 | 39 | 0.130 |
Why?
| | Prospective Studies | 2 | 2021 | 7111 | 0.130 |
Why?
| | Coenzyme A Ligases | 1 | 2016 | 13 | 0.130 |
Why?
| | Obstetrics | 1 | 2018 | 161 | 0.130 |
Why?
| | Echocardiography | 1 | 2019 | 628 | 0.130 |
Why?
| | Amino Acid Transport System y+L | 1 | 2015 | 4 | 0.130 |
Why?
| | Fatty Acid Binding Protein 3 | 1 | 2015 | 5 | 0.130 |
Why?
| | Caspase 3 | 2 | 2014 | 245 | 0.130 |
Why?
| | Animal Nutritional Physiological Phenomena | 1 | 2015 | 14 | 0.130 |
Why?
| | Androgens | 1 | 2017 | 177 | 0.130 |
Why?
| | Excitatory Amino Acids | 1 | 2015 | 7 | 0.120 |
Why?
| | Transport Vesicles | 1 | 2015 | 18 | 0.120 |
Why?
| | Gynecology | 1 | 2018 | 175 | 0.120 |
Why?
| | Proteomics | 1 | 2022 | 1062 | 0.120 |
Why?
| | Diet | 3 | 2022 | 1212 | 0.120 |
Why?
| | Dietary Sucrose | 1 | 2015 | 48 | 0.120 |
Why?
| | Hepatocytes | 2 | 2014 | 216 | 0.120 |
Why?
| | Anti-Inflammatory Agents | 1 | 2019 | 480 | 0.120 |
Why?
| | Heart | 1 | 2019 | 637 | 0.120 |
Why?
| | Lipase | 1 | 2015 | 66 | 0.120 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2017 | 272 | 0.120 |
Why?
| | Autophagy | 1 | 2017 | 268 | 0.120 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2015 | 147 | 0.120 |
Why?
| | Interleukin-1beta | 2 | 2014 | 372 | 0.110 |
Why?
| | Environmental Exposure | 1 | 2018 | 463 | 0.110 |
Why?
| | Analysis of Variance | 2 | 2017 | 1287 | 0.110 |
Why?
| | Myocardium | 1 | 2019 | 980 | 0.110 |
Why?
| | Ovarian Neoplasms | 1 | 2019 | 487 | 0.110 |
Why?
| | Prognosis | 2 | 2019 | 3791 | 0.110 |
Why?
| | bcl-2-Associated X Protein | 1 | 2013 | 55 | 0.110 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2017 | 367 | 0.110 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2021 | 2436 | 0.110 |
Why?
| | Epigenesis, Genetic | 1 | 2018 | 613 | 0.110 |
Why?
| | Transfection | 1 | 2015 | 911 | 0.110 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2013 | 31 | 0.100 |
Why?
| | Receptor, IGF Type 1 | 3 | 2021 | 65 | 0.100 |
Why?
| | Ceramides | 1 | 2014 | 112 | 0.100 |
Why?
| | Blood Urea Nitrogen | 1 | 2012 | 53 | 0.100 |
Why?
| | Longitudinal Studies | 1 | 2020 | 2714 | 0.100 |
Why?
| | Apoptosis | 2 | 2019 | 2503 | 0.100 |
Why?
| | Protein Subunits | 1 | 2013 | 234 | 0.100 |
Why?
| | Mitochondria | 1 | 2019 | 877 | 0.100 |
Why?
| | Hyperandrogenism | 1 | 2012 | 18 | 0.100 |
Why?
| | Liver Neoplasms | 1 | 2017 | 640 | 0.100 |
Why?
| | Energy Metabolism | 2 | 2015 | 871 | 0.100 |
Why?
| | Muscle, Skeletal | 1 | 2022 | 1614 | 0.100 |
Why?
| | Oxygen | 1 | 2017 | 911 | 0.100 |
Why?
| | MicroRNAs | 1 | 2018 | 678 | 0.100 |
Why?
| | Brain | 1 | 2023 | 2678 | 0.090 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2011 | 21 | 0.090 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2012 | 160 | 0.090 |
Why?
| | Biomedical Research | 1 | 2017 | 637 | 0.090 |
Why?
| | Phosphatidylcholines | 2 | 2023 | 146 | 0.090 |
Why?
| | Mass Screening | 1 | 2018 | 1148 | 0.090 |
Why?
| | Colorado | 1 | 2020 | 4415 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2018 | 1278 | 0.080 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1265 | 0.080 |
Why?
| | Stromal Cells | 2 | 2021 | 107 | 0.080 |
Why?
| | Mothers | 1 | 2015 | 728 | 0.080 |
Why?
| | Cross-Sectional Studies | 4 | 2022 | 5061 | 0.080 |
Why?
| | Inflammation | 2 | 2022 | 2735 | 0.070 |
Why?
| | Microscopy, Fluorescence | 2 | 2021 | 400 | 0.070 |
Why?
| | Immunity, Innate | 1 | 2014 | 804 | 0.070 |
Why?
| | Pregnancy Trimester, Third | 1 | 2008 | 109 | 0.070 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenases | 1 | 2007 | 3 | 0.070 |
Why?
| | Sex Factors | 1 | 2013 | 1966 | 0.070 |
Why?
| | Glucose Transporter Type 3 | 1 | 2007 | 13 | 0.070 |
Why?
| | Amino Acid Transport System y+ | 1 | 2007 | 8 | 0.070 |
Why?
| | Hyperlipoproteinemia Type I | 1 | 2007 | 7 | 0.070 |
Why?
| | Fluorescent Antibody Technique | 2 | 2018 | 376 | 0.070 |
Why?
| | Sex Characteristics | 2 | 2023 | 737 | 0.070 |
Why?
| | Uterus | 2 | 2019 | 206 | 0.070 |
Why?
| | Oxidative Stress | 2 | 2018 | 1269 | 0.070 |
Why?
| | Lipoprotein Lipase | 1 | 2007 | 59 | 0.070 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2006 | 21 | 0.070 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2018 | 182 | 0.070 |
Why?
| | Glucose Clamp Technique | 1 | 2007 | 194 | 0.060 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3079 | 0.060 |
Why?
| | Mass Spectrometry | 2 | 2021 | 716 | 0.060 |
Why?
| | Interviews as Topic | 1 | 2008 | 717 | 0.060 |
Why?
| | Lentivirus | 1 | 2025 | 53 | 0.060 |
Why?
| | Osmolar Concentration | 1 | 2004 | 166 | 0.060 |
Why?
| | Lactic Acid | 1 | 2006 | 302 | 0.060 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2004 | 197 | 0.060 |
Why?
| | Ephrin-A3 | 1 | 2024 | 1 | 0.060 |
Why?
| | Ephrins | 1 | 2024 | 8 | 0.060 |
Why?
| | Microscopy, Electron | 1 | 2004 | 426 | 0.060 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2017 | 163 | 0.060 |
Why?
| | Ether | 1 | 2023 | 7 | 0.050 |
Why?
| | Ethyl Ethers | 1 | 2023 | 4 | 0.050 |
Why?
| | Plasmalogens | 1 | 2023 | 6 | 0.050 |
Why?
| | Ethers | 1 | 2023 | 16 | 0.050 |
Why?
| | Lipocalin-2 | 1 | 2024 | 75 | 0.050 |
Why?
| | Connexins | 1 | 2024 | 51 | 0.050 |
Why?
| | Phosphatidylethanolamines | 1 | 2023 | 74 | 0.050 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 2 | 2014 | 161 | 0.050 |
Why?
| | Electrolytes | 1 | 2003 | 60 | 0.050 |
Why?
| | Cell Cycle Proteins | 1 | 2007 | 586 | 0.050 |
Why?
| | Body Composition | 1 | 2007 | 649 | 0.050 |
Why?
| | Pregnancy, High-Risk | 1 | 2002 | 15 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2007 | 2011 | 0.050 |
Why?
| | Interleukin-6 | 1 | 2006 | 720 | 0.050 |
Why?
| | Pregnant Women | 1 | 2023 | 114 | 0.050 |
Why?
| | Insulin, Regular, Human | 1 | 2022 | 43 | 0.050 |
Why?
| | Insulin Receptor Substrate Proteins | 2 | 2013 | 59 | 0.050 |
Why?
| | Maleimides | 1 | 2021 | 21 | 0.050 |
Why?
| | Cell Shape | 1 | 2021 | 55 | 0.050 |
Why?
| | Receptors, Erythropoietin | 1 | 2021 | 20 | 0.050 |
Why?
| | Norway | 1 | 2021 | 42 | 0.050 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2021 | 149 | 0.050 |
Why?
| | Esterification | 1 | 2020 | 9 | 0.050 |
Why?
| | Cholesterol | 1 | 2023 | 412 | 0.040 |
Why?
| | Metabolome | 1 | 2024 | 338 | 0.040 |
Why?
| | Parity | 1 | 2021 | 120 | 0.040 |
Why?
| | Epithelial Cells | 1 | 2007 | 1065 | 0.040 |
Why?
| | Erythropoietin | 1 | 2021 | 86 | 0.040 |
Why?
| | Reference Values | 1 | 2002 | 793 | 0.040 |
Why?
| | Receptors, Amino Acid | 1 | 2020 | 25 | 0.040 |
Why?
| | NF-kappa B | 2 | 2014 | 653 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 833 | 0.040 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 274 | 0.040 |
Why?
| | Neoplasms, Cystic, Mucinous, and Serous | 1 | 2019 | 25 | 0.040 |
Why?
| | Adenosine Triphosphatases | 1 | 2020 | 161 | 0.040 |
Why?
| | Erythrocytes | 1 | 2024 | 672 | 0.040 |
Why?
| | Sodium | 1 | 2020 | 204 | 0.040 |
Why?
| | Cell Cycle Checkpoints | 1 | 2019 | 95 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 169 | 0.040 |
Why?
| | Arachidonic Acids | 1 | 2018 | 59 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2021 | 529 | 0.040 |
Why?
| | Hippocampus | 1 | 2024 | 874 | 0.040 |
Why?
| | Neoplasm Grading | 1 | 2019 | 285 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2024 | 748 | 0.040 |
Why?
| | Adolescent | 3 | 2019 | 20378 | 0.040 |
Why?
| | Indoles | 1 | 2021 | 385 | 0.040 |
Why?
| | Mitosis | 1 | 2019 | 180 | 0.040 |
Why?
| | Perilipin-2 | 1 | 2018 | 36 | 0.040 |
Why?
| | Environmental Health | 1 | 2018 | 37 | 0.040 |
Why?
| | Phagosomes | 1 | 2017 | 42 | 0.040 |
Why?
| | Lipogenesis | 1 | 2017 | 59 | 0.030 |
Why?
| | Sheep | 1 | 2020 | 836 | 0.030 |
Why?
| | Lysosomes | 1 | 2017 | 138 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1033 | 0.030 |
Why?
| | Phosphoserine | 1 | 2015 | 33 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2019 | 1501 | 0.030 |
Why?
| | Blotting, Western | 2 | 2010 | 1205 | 0.030 |
Why?
| | Lipid Peroxidation | 1 | 2015 | 151 | 0.030 |
Why?
| | Corticosterone | 1 | 2016 | 219 | 0.030 |
Why?
| | Adenylate Kinase | 1 | 2014 | 26 | 0.030 |
Why?
| | Caspase 10 | 1 | 2014 | 5 | 0.030 |
Why?
| | Chorionic Gonadotropin | 1 | 2014 | 80 | 0.030 |
Why?
| | Cell Movement | 1 | 2018 | 945 | 0.030 |
Why?
| | Time Factors | 1 | 2004 | 6550 | 0.030 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2014 | 110 | 0.030 |
Why?
| | GRB2 Adaptor Protein | 1 | 2013 | 13 | 0.030 |
Why?
| | Oxidoreductases | 1 | 2014 | 92 | 0.030 |
Why?
| | Transcription Factors | 1 | 2021 | 1650 | 0.030 |
Why?
| | Transgenes | 1 | 2014 | 177 | 0.030 |
Why?
| | Incidence | 1 | 2019 | 2641 | 0.030 |
Why?
| | Estradiol Dehydrogenases | 1 | 2012 | 1 | 0.030 |
Why?
| | Estrous Cycle | 1 | 2012 | 21 | 0.030 |
Why?
| | Binding Sites | 1 | 2015 | 1252 | 0.020 |
Why?
| | Metabolic Networks and Pathways | 1 | 2013 | 178 | 0.020 |
Why?
| | Random Allocation | 1 | 2012 | 346 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2058 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 3215 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2019 | 2391 | 0.020 |
Why?
| | Receptors, Androgen | 1 | 2012 | 147 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2831 | 0.020 |
Why?
| | Dexamethasone | 1 | 2013 | 346 | 0.020 |
Why?
| | Toll-Like Receptor 4 | 1 | 2012 | 263 | 0.020 |
Why?
| | Attitude of Health Personnel | 1 | 2018 | 1093 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2012 | 426 | 0.020 |
Why?
| | Cell Survival | 1 | 2012 | 1086 | 0.020 |
Why?
| | Blood Pressure | 1 | 2016 | 1731 | 0.020 |
Why?
| | Middle Aged | 2 | 2019 | 31102 | 0.020 |
Why?
| | Gene Expression | 1 | 2013 | 1471 | 0.020 |
Why?
| | Fat Emulsions, Intravenous | 1 | 2007 | 28 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 1037 | 0.020 |
Why?
| | Carbon Radioisotopes | 1 | 2006 | 35 | 0.020 |
Why?
| | Permeability | 1 | 2006 | 157 | 0.020 |
Why?
| | Cytokines | 1 | 2014 | 2015 | 0.020 |
Why?
| | Amniotic Fluid | 1 | 2006 | 86 | 0.020 |
Why?
| | Protons | 1 | 2006 | 80 | 0.020 |
Why?
| | Aged | 1 | 2024 | 22052 | 0.010 |
Why?
| | Muscle Proteins | 1 | 2006 | 220 | 0.010 |
Why?
| | Ultrasonography, Prenatal | 1 | 2006 | 270 | 0.010 |
Why?
| | Phenotype | 1 | 2005 | 3076 | 0.010 |
Why?
|
|
Jansson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|